EEG Biofeedback as a Treatment for Substance Use Disorders: Review, Rating of Efficacy, and Recommendations for Further Research
Share
Study at a glance
- Area
- Addiction
- Study type
- Review & meta-analysis
- Authors
- Sokhadze TM, Cannon RL, Trudeau DL
- Journal
- Applied Psychophysiology and Biofeedback
- Year
- 2008
- Protocol
- alpha-theta and beta neurofeedback (review)
Key findings
- Alpha-theta training rated probably efficacious for alcoholism
- Alpha-theta plus beta training, combined with residential treatment programs, rated probably efficacious for stimulant and mixed substance abuse
- Neurofeedback may enhance certain outcomes when added to other therapies
- The authors discuss research design considerations and describe current studies
A review of three decades of EEG biofeedback (neurofeedback) for substance use disorders, which often occur alongside other conditions and several types of EEG abnormality. Neurofeedback has usually been combined with other therapies. Using efficacy criteria adapted from two professional biofeedback and neurofeedback societies, the authors rate alpha-theta training as probably efficacious, either alone for alcoholism or combined with beta training and residential treatment for stimulant and mixed substance abuse.